H. Ralph Snodgrass - Dec 31, 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
PRES./CHIEF SCIENTIFIC OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Dec 31, 2021
Transactions value $
$6,005
Form type
4
Date filed
1/3/2022, 03:19 PM
Previous filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $6.01K +3.62K +5.91% $1.66 65K Dec 31, 2021 Direct F1
holding VTGN Common Stock 33.9K Dec 31, 2021 By H. Ralph Snodgrass Living Trust, dated 10/2/2008
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)